- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Capex | Q2 2025 · Mar 31, 2025 | $2.13M |
| Capex | Q2 2025 · Mar 31, 2024 | $1.87M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $137.19M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $141.6M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $234.29M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | $237.57M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $97.17M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $133.44M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $234.82M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $281.08M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $243.89M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $294.12M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $649.74M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $700.49M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 31.54M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 31.53M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $124K |
| Dividends Paid | Q2 2025 · Mar 31, 2024 | $13.37M |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | $35.02M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.34 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.75 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.35 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.77 |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $11.69M |
| Sga Expense restated | Q2 2025 · Mar 31, 2024 | $21.21M |
| Net Income | Q2 2025 · Mar 31, 2024 | $5.86M |
| Net Income | Q2 2025 · Mar 31, 2024 | $12.86M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | $12.13M |
| Operating Income restated | Q2 2025 · Mar 31, 2024 | $22.75M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $49.65M |
| Revenue restated | Q2 2025 · Mar 31, 2024 | $96.16M |